Evaluation of a combination of third generation cephalosporin, ESBL inhibitor and MBL inhibitor: An in vitro study to assess the efficacy for treatment of carbapenemase producing Gram negative bacilli. - Current Issue

Evaluation of a combination of third generation cephalosporin, ESBL inhibitor and MBL inhibitor: An in vitro study to assess the efficacy for treatment of carbapenemase producing Gram negative bacilli. - Current Issue - IJSR